Concord Biotech IPO: Concord Biotech shares listed at an 21.5% premium over IPO price on NSE and BSE amid positive domestic market. The share debuted at Rs 819.9 apiece on the BSE, as compared to the issue price of Rs 741. Ahead of the public issue listing, Concord Biotech shares’ GMP rose to Rs 122 […]